Nystatin Oral Suspension Articles
Improved anti-fungal drug targets oncology market
16 June 2008
Pfizer/B-MS initiate Ph III apixaban study
16 June 2008
Januvia lowers hypoglycemia risk vs glipizide
16 June 2008
Novo Nordisk's liraglutide superior to glimepiride
16 June 2008
66% of Lantus patients meet ADA's 7% target
16 June 2008
Japan stock market week to June 9, 2008
16 June 2008
BZL101 to advance into US Ph II trials this year
9 June 2008
Japan stock market week to June 2, 2008
9 June 2008
Gilead acquires Navitas' cicletanine assets
9 June 2008
DORBio opens new EU office in UK
9 June 2008
Bayer's Xarelto wins out in study
9 June 2008
Promacta gets nod from US FDA panel
9 June 2008
FDA accepts NDA on Watson's OAB gel
9 June 2008
Asthma uncontrolled in 40% of US patients
2 June 2008
Shionogi's Crestor boosts fiscal 2007
2 June 2008
Approval for Novartis' generic Betaferon in EU
2 June 2008
S-P to initiate Ph III boceprevir program
2 June 2008
Jazz' net loss deepens to $46.7M in 1st qtr
26 May 2008
S Africa's expanding diabetes market
26 May 2008
MS drug pipeline update from Bayer Schering
26 May 2008
Japan stock market week to May 19, 2008
26 May 2008
Mission Pharmacal launches Ferralet 90 in USA
26 May 2008
Debiopharm signs Salvacyl market deal
26 May 2008
GSK launches once-daily ReQuip XL in UK
19 May 2008
Spherix reports Naturlose Ph III results
19 May 2008
Ziopharm granted orphan status for STS treatment
19 May 2008
Barr shares fall 15% on disappointing 1st qtr
19 May 2008
Generics cut King's 1st-qtr income 16%
19 May 2008
RotaTeq "100% effective from first dose"
19 May 2008
Nitrate-rich foods protect stomach ulcers
19 May 2008
Ligand falls into loss in 1st qtr
19 May 2008
AstraZeneca submits MAA for Iressa
12 May 2008
J&J drug: longer time to relapse than quetiapine
12 May 2008
Bayer Schering to market Yaz in EU
12 May 2008
Japan stock market week to Apr 28, 2008
5 May 2008
Diabetes drugs connected to fractures
5 May 2008
Promising Ph IIa data on Roche's R1626
5 May 2008
S-P's boceprevir sees 57% SVR at 28 weeks
5 May 2008
UK "No" for another cancer drug
5 May 2008
Pharming's Prodarsan enters Ph I testing
5 May 2008
Pfizer to launch Champix in Japan
28 April 2008
Novartis markets vildagliptin in UK
28 April 2008
Raptor starts Ph IIa Convivia trial
28 April 2008
EC clears Celgene's Thalidomide in MM
28 April 2008
Schering-Plough to deliver Hep C data
28 April 2008
Boehringer Ingelheim launch Pradaxa in UK
28 April 2008
Paratek gathers $40M for oral antibiotic
21 April 2008
7TM gets milestone from Ortho-McNeil
21 April 2008
44% bioavailability for Poniard's picoplatin
21 April 2008
Rx-to-OTC switching making comeback
21 April 2008
EPO revokes an OSI DPP-4 patent
21 April 2008
Generex insulin spray enters US Ph III trial
21 April 2008
Complete response to hold on anemia drugs
14 April 2008
Stock Commentary - New York week to April 7, 2008
14 April 2008
Genasense delay causes Genta to cut 30% jobs
14 April 2008
Spiriva and Micardis boost Boehringer's 2007 sales 8.8%, as profit jumps 4.8% to $2.8M
14 April 2008
Abraxis pays initial $15M for Shimoda
14 April 2008
Millennium accepts $8.8B bid from Takeda
14 April 2008
EntreMed commences Ph I trial of MKC-1
7 April 2008
EC approves Boeh Ing's Pradaxa in VTE
7 April 2008
FDA investigates suicide link with Singulair
7 April 2008
Akesis closes $2M placing
31 March 2008
Stock Commentary - Europe - week to March 24, 2008
31 March 2008
Hollis-Eden's 4th-qtr net loss narrows to $5.2M on payments for Triolex; files four US INDs in 2007
31 March 2008
Japan stock market week to March 24, 2008
31 March 2008
Delay to EU approval of GSK
31 March 2008
Cytopia selects JAK2 MPDS candidate
31 March 2008
China Aoxing acquires LRT for $10.8M
24 March 2008
Japan stock market week to March 17, 2008
24 March 2008
HalcyGen's SUBA-Itraconazole in commercial production
24 March 2008
Generex' Oral-lyn packaged for trials
17 March 2008
ACE Bio collaborates with PATH on ETEC vacc
17 March 2008
Japan stock market week to March 10, 2008
17 March 2008
- Is failure to adopt business process management putting the pharma industry at risk?
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Elan makes "transformational" acquisitions and a divestment
